Solid phase peptide synthesis (SPPS) is a technique for peptide synthesis. It can be defined as a process in which a peptide anchored by its c-terminus to an insoluble polymer is assembled by the successive addition of the protected amino acids constituting its sequence. Liquid-phase peptide synthesis is a hybrid method that combines the advantages of solution-phase and solid-phase chemistry. The approach is best suited for the synthesis of short peptides (up to 20 amino acids) for purity-sensitive applications such as: Therapy.
The global Liquid and Solid Phase Peptide Synthesis market was valued at US$ 387 million in 2023 and is anticipated to reach US$ 512.9 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
North American market for Liquid and Solid Phase Peptide Synthesis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Liquid and Solid Phase Peptide Synthesis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Liquid and Solid Phase Peptide Synthesis in Commercial is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Liquid and Solid Phase Peptide Synthesis include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT and Genscript, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Liquid and Solid Phase Peptide Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid and Solid Phase Peptide Synthesis.
Report Scope
The Liquid and Solid Phase Peptide Synthesis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liquid and Solid Phase Peptide Synthesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid and Solid Phase Peptide Synthesis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
AnaSpec
Segment by Type
Liquid Phase Peptide
Solid Phase Peptide
Segment by Application
Commercial
Scientific Research
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid and Solid Phase Peptide Synthesis companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liquid and Solid Phase Peptide Synthesis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liquid Phase Peptide
1.2.3 Solid Phase Peptide
1.3 Market by Application
1.3.1 Global Liquid and Solid Phase Peptide Synthesis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Scientific Research
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liquid and Solid Phase Peptide Synthesis Market Perspective (2019-2030)
2.2 Liquid and Solid Phase Peptide Synthesis Growth Trends by Region
2.2.1 Global Liquid and Solid Phase Peptide Synthesis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liquid and Solid Phase Peptide Synthesis Historic Market Size by Region (2019-2024)
2.2.3 Liquid and Solid Phase Peptide Synthesis Forecasted Market Size by Region (2025-2030)
2.3 Liquid and Solid Phase Peptide Synthesis Market Dynamics
2.3.1 Liquid and Solid Phase Peptide Synthesis Industry Trends
2.3.2 Liquid and Solid Phase Peptide Synthesis Market Drivers
2.3.3 Liquid and Solid Phase Peptide Synthesis Market Challenges
2.3.4 Liquid and Solid Phase Peptide Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liquid and Solid Phase Peptide Synthesis Players by Revenue
3.1.1 Global Top Liquid and Solid Phase Peptide Synthesis Players by Revenue (2019-2024)
3.1.2 Global Liquid and Solid Phase Peptide Synthesis Revenue Market Share by Players (2019-2024)
3.2 Global Liquid and Solid Phase Peptide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liquid and Solid Phase Peptide Synthesis Revenue
3.4 Global Liquid and Solid Phase Peptide Synthesis Market Concentration Ratio
3.4.1 Global Liquid and Solid Phase Peptide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid and Solid Phase Peptide Synthesis Revenue in 2023
3.5 Liquid and Solid Phase Peptide Synthesis Key Players Head office and Area Served
3.6 Key Players Liquid and Solid Phase Peptide Synthesis Product Solution and Service
3.7 Date of Enter into Liquid and Solid Phase Peptide Synthesis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liquid and Solid Phase Peptide Synthesis Breakdown Data by Type
4.1 Global Liquid and Solid Phase Peptide Synthesis Historic Market Size by Type (2019-2024)
4.2 Global Liquid and Solid Phase Peptide Synthesis Forecasted Market Size by Type (2025-2030)
5 Liquid and Solid Phase Peptide Synthesis Breakdown Data by Application
5.1 Global Liquid and Solid Phase Peptide Synthesis Historic Market Size by Application (2019-2024)
5.2 Global Liquid and Solid Phase Peptide Synthesis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liquid and Solid Phase Peptide Synthesis Market Size (2019-2030)
6.2 North America Liquid and Solid Phase Peptide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Liquid and Solid Phase Peptide Synthesis Market Size by Country (2019-2024)
6.4 North America Liquid and Solid Phase Peptide Synthesis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liquid and Solid Phase Peptide Synthesis Market Size (2019-2030)
7.2 Europe Liquid and Solid Phase Peptide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Liquid and Solid Phase Peptide Synthesis Market Size by Country (2019-2024)
7.4 Europe Liquid and Solid Phase Peptide Synthesis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liquid and Solid Phase Peptide Synthesis Market Size (2019-2030)
8.2 Asia-Pacific Liquid and Solid Phase Peptide Synthesis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Liquid and Solid Phase Peptide Synthesis Market Size by Region (2019-2024)
8.4 Asia-Pacific Liquid and Solid Phase Peptide Synthesis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liquid and Solid Phase Peptide Synthesis Market Size (2019-2030)
9.2 Latin America Liquid and Solid Phase Peptide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Liquid and Solid Phase Peptide Synthesis Market Size by Country (2019-2024)
9.4 Latin America Liquid and Solid Phase Peptide Synthesis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liquid and Solid Phase Peptide Synthesis Market Size (2019-2030)
10.2 Middle East & Africa Liquid and Solid Phase Peptide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Liquid and Solid Phase Peptide Synthesis Market Size by Country (2019-2024)
10.4 Middle East & Africa Liquid and Solid Phase Peptide Synthesis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Detail
11.1.2 Bachem Business Overview
11.1.3 Bachem Liquid and Solid Phase Peptide Synthesis Introduction
11.1.4 Bachem Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Detail
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Liquid and Solid Phase Peptide Synthesis Introduction
11.2.4 PolyPeptide Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.2.5 PolyPeptide Recent Development
11.3 CordenPharma
11.3.1 CordenPharma Company Detail
11.3.2 CordenPharma Business Overview
11.3.3 CordenPharma Liquid and Solid Phase Peptide Synthesis Introduction
11.3.4 CordenPharma Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.3.5 CordenPharma Recent Development
11.4 AmbioPharm
11.4.1 AmbioPharm Company Detail
11.4.2 AmbioPharm Business Overview
11.4.3 AmbioPharm Liquid and Solid Phase Peptide Synthesis Introduction
11.4.4 AmbioPharm Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.4.5 AmbioPharm Recent Development
11.5 USV Peptides
11.5.1 USV Peptides Company Detail
11.5.2 USV Peptides Business Overview
11.5.3 USV Peptides Liquid and Solid Phase Peptide Synthesis Introduction
11.5.4 USV Peptides Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.5.5 USV Peptides Recent Development
11.6 Thermofischer
11.6.1 Thermofischer Company Detail
11.6.2 Thermofischer Business Overview
11.6.3 Thermofischer Liquid and Solid Phase Peptide Synthesis Introduction
11.6.4 Thermofischer Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.6.5 Thermofischer Recent Development
11.7 Bio Basic
11.7.1 Bio Basic Company Detail
11.7.2 Bio Basic Business Overview
11.7.3 Bio Basic Liquid and Solid Phase Peptide Synthesis Introduction
11.7.4 Bio Basic Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.7.5 Bio Basic Recent Development
11.8 JPT
11.8.1 JPT Company Detail
11.8.2 JPT Business Overview
11.8.3 JPT Liquid and Solid Phase Peptide Synthesis Introduction
11.8.4 JPT Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.8.5 JPT Recent Development
11.9 Genscript
11.9.1 Genscript Company Detail
11.9.2 Genscript Business Overview
11.9.3 Genscript Liquid and Solid Phase Peptide Synthesis Introduction
11.9.4 Genscript Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.9.5 Genscript Recent Development
11.10 Xinbang Pharma
11.10.1 Xinbang Pharma Company Detail
11.10.2 Xinbang Pharma Business Overview
11.10.3 Xinbang Pharma Liquid and Solid Phase Peptide Synthesis Introduction
11.10.4 Xinbang Pharma Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.10.5 Xinbang Pharma Recent Development
11.11 ScinoPharm
11.11.1 ScinoPharm Company Detail
11.11.2 ScinoPharm Business Overview
11.11.3 ScinoPharm Liquid and Solid Phase Peptide Synthesis Introduction
11.11.4 ScinoPharm Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.11.5 ScinoPharm Recent Development
11.12 SN Biopharm
11.12.1 SN Biopharm Company Detail
11.12.2 SN Biopharm Business Overview
11.12.3 SN Biopharm Liquid and Solid Phase Peptide Synthesis Introduction
11.12.4 SN Biopharm Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.12.5 SN Biopharm Recent Development
11.13 CBL
11.13.1 CBL Company Detail
11.13.2 CBL Business Overview
11.13.3 CBL Liquid and Solid Phase Peptide Synthesis Introduction
11.13.4 CBL Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.13.5 CBL Recent Development
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Detail
11.14.2 Piramal Pharma Business Overview
11.14.3 Piramal Pharma Liquid and Solid Phase Peptide Synthesis Introduction
11.14.4 Piramal Pharma Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.14.5 Piramal Pharma Recent Development
11.15 CPC Scientific
11.15.1 CPC Scientific Company Detail
11.15.2 CPC Scientific Business Overview
11.15.3 CPC Scientific Liquid and Solid Phase Peptide Synthesis Introduction
11.15.4 CPC Scientific Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.15.5 CPC Scientific Recent Development
11.16 AnaSpec
11.16.1 AnaSpec Company Detail
11.16.2 AnaSpec Business Overview
11.16.3 AnaSpec Liquid and Solid Phase Peptide Synthesis Introduction
11.16.4 AnaSpec Revenue in Liquid and Solid Phase Peptide Synthesis Business (2019-2024)
11.16.5 AnaSpec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
AnaSpec
听
听
*If Applicable.
